Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200561263> ?p ?o ?g. }
- W4200561263 endingPage "656" @default.
- W4200561263 startingPage "647" @default.
- W4200561263 abstract "Immune checkpoint inhibitor (ICI)-induced hepatitis belongs to the frequently occurring immune-related adverse events (irAEs), particularly with the combination therapy involving ipilimumab and nivolumab. However, predisposing factors predicting the occurrence of ICI-induced hepatitis are barely known. We investigated the association of preexisting autoantibodies in the development of ICI-induced hepatitis in a prospective cohort of cancer patients.Data from a prospective biomarker cohort comprising melanoma and non-small cell lung cancer (NSCLC) patients were used to analyze the incidence of ICI-induced hepatitis, putatively associated factors, and outcome.40 patients with melanoma and 91 patients with NSCLC received ICI between July 2016 and May 2019. 11 patients developed ICI-induced hepatitis (8.4%). Prior to treatment, 45.5% of patients in the hepatitis cohort and 43.8% of the control cohort showed elevated titers of autoantibodies commonly associated with autoimmune liver diseases (p = 0.82). We found two nominally significant associations between the occurrence of ICI-induced hepatitis and HLA alleles associated with autoimmune liver diseases among NSCLC patients. Of note, significantly more patients with ICI-induced hepatitis developed additional irAEs in other organs (p = 0.0001). Neither overall nor progression-free survival was affected in the hepatitis group.We found nominally significant associations of ICI-induced hepatitis with two HLA alleles. ICI-induced hepatitis showed no correlation with liver-specific autoantibodies, but frequently co-occurred with irAEs affecting other organs. Unlike other irAEs, ICI-induced hepatitis is not associated with a better prognosis." @default.
- W4200561263 created "2021-12-31" @default.
- W4200561263 creator A5002059133 @default.
- W4200561263 creator A5005687258 @default.
- W4200561263 creator A5019789404 @default.
- W4200561263 creator A5020708921 @default.
- W4200561263 creator A5022167252 @default.
- W4200561263 creator A5026194740 @default.
- W4200561263 creator A5026846457 @default.
- W4200561263 creator A5030812101 @default.
- W4200561263 creator A5036602887 @default.
- W4200561263 creator A5044032162 @default.
- W4200561263 creator A5064134027 @default.
- W4200561263 creator A5084754410 @default.
- W4200561263 creator A5085610901 @default.
- W4200561263 creator A5085975348 @default.
- W4200561263 creator A5087984672 @default.
- W4200561263 creator A5090698825 @default.
- W4200561263 date "2021-12-07" @default.
- W4200561263 modified "2023-09-27" @default.
- W4200561263 title "Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients" @default.
- W4200561263 cites W1530211033 @default.
- W4200561263 cites W1766890167 @default.
- W4200561263 cites W1979004604 @default.
- W4200561263 cites W2005950142 @default.
- W4200561263 cites W2019607817 @default.
- W4200561263 cites W2057523272 @default.
- W4200561263 cites W2060470911 @default.
- W4200561263 cites W2113183888 @default.
- W4200561263 cites W2179179825 @default.
- W4200561263 cites W2291096806 @default.
- W4200561263 cites W2338263211 @default.
- W4200561263 cites W2521641698 @default.
- W4200561263 cites W2522875140 @default.
- W4200561263 cites W2579289641 @default.
- W4200561263 cites W2599076725 @default.
- W4200561263 cites W2765836977 @default.
- W4200561263 cites W2770404972 @default.
- W4200561263 cites W2786816161 @default.
- W4200561263 cites W2788726176 @default.
- W4200561263 cites W2789465456 @default.
- W4200561263 cites W2794343662 @default.
- W4200561263 cites W2794538118 @default.
- W4200561263 cites W2797257550 @default.
- W4200561263 cites W2799996199 @default.
- W4200561263 cites W2870583179 @default.
- W4200561263 cites W2888255417 @default.
- W4200561263 cites W2898296484 @default.
- W4200561263 cites W2898305030 @default.
- W4200561263 cites W2905314444 @default.
- W4200561263 cites W2907792173 @default.
- W4200561263 cites W2913249270 @default.
- W4200561263 cites W2921256116 @default.
- W4200561263 cites W2924328881 @default.
- W4200561263 cites W2944975005 @default.
- W4200561263 cites W2957570007 @default.
- W4200561263 cites W2969426509 @default.
- W4200561263 cites W2980505578 @default.
- W4200561263 cites W2996733487 @default.
- W4200561263 cites W3097399706 @default.
- W4200561263 cites W3131365592 @default.
- W4200561263 cites W4294116629 @default.
- W4200561263 doi "https://doi.org/10.1007/s00432-021-03870-6" @default.
- W4200561263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34874490" @default.
- W4200561263 hasPublicationYear "2021" @default.
- W4200561263 type Work @default.
- W4200561263 citedByCount "4" @default.
- W4200561263 countsByYear W42005612632022 @default.
- W4200561263 countsByYear W42005612632023 @default.
- W4200561263 crossrefType "journal-article" @default.
- W4200561263 hasAuthorship W4200561263A5002059133 @default.
- W4200561263 hasAuthorship W4200561263A5005687258 @default.
- W4200561263 hasAuthorship W4200561263A5019789404 @default.
- W4200561263 hasAuthorship W4200561263A5020708921 @default.
- W4200561263 hasAuthorship W4200561263A5022167252 @default.
- W4200561263 hasAuthorship W4200561263A5026194740 @default.
- W4200561263 hasAuthorship W4200561263A5026846457 @default.
- W4200561263 hasAuthorship W4200561263A5030812101 @default.
- W4200561263 hasAuthorship W4200561263A5036602887 @default.
- W4200561263 hasAuthorship W4200561263A5044032162 @default.
- W4200561263 hasAuthorship W4200561263A5064134027 @default.
- W4200561263 hasAuthorship W4200561263A5084754410 @default.
- W4200561263 hasAuthorship W4200561263A5085610901 @default.
- W4200561263 hasAuthorship W4200561263A5085975348 @default.
- W4200561263 hasAuthorship W4200561263A5087984672 @default.
- W4200561263 hasAuthorship W4200561263A5090698825 @default.
- W4200561263 hasBestOaLocation W42005612631 @default.
- W4200561263 hasConcept C121608353 @default.
- W4200561263 hasConcept C126322002 @default.
- W4200561263 hasConcept C143998085 @default.
- W4200561263 hasConcept C159654299 @default.
- W4200561263 hasConcept C163764329 @default.
- W4200561263 hasConcept C188816634 @default.
- W4200561263 hasConcept C203014093 @default.
- W4200561263 hasConcept C2776029263 @default.
- W4200561263 hasConcept C2776231280 @default.
- W4200561263 hasConcept C2776455275 @default.
- W4200561263 hasConcept C2777203481 @default.